// App-Quantinova.ai

159 : Confirmed three-year RFS and OS of the randomized trial of adjuvant S-1 versus S-1 plus docetaxel after curative resection of pStage III gastric cancer (JACCRO GC-07).

Researchers

Presenter

  • Kazuhiro Yoshida

Principal Investigators

  • Yasuhiro Kodera

  • Mitsugu Kochi

  • Takeshi Sano

  • Yoshihiro Kakeji

  • Wataru Ichikawa

  • Shintaro Kurahashi

  • Hironori Yamaguchi

  • Takahiro Toyokawa

  • Masato Nakamura

  • Kazumasa Fujitani

  • Yoshinari Mochizuki

  • Mitsuhiko Ota

  • Jun Hihara

  • Yoichi Makari

  • Atsushi Takeno

  • Masahiro Takeuchi

  • Masashi Fujii

Medical Centers

  • Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • Nagoya University Graduate School of Medicine, Departmant of Gastroenterology and Hepatology, Nagoya, Japan

  • Department of Digestive Surgery, Nihon University Itabashi Hospital, Tokyo, Japan

  • Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  • Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan

  • Division of Medical Oncology, Showa University Northern Yokohama Hospital, Yokohama, Japan

  • Department of Gastroenterological Surgery, Saitama Medical University, Saitama, Japan

  • Jichi Medical University, Tochigi, Japan

  • Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan

  • Department of Surgery, Osaka General Medical Center, Osaka, Japan

  • Ogaki Municipal Hospital, Ogaki, Japan

  • National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

  • Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan

  • Sendai City Medical Center, Sendai, Japan

  • Department of Surgery, Osaka Rosai Hospital, Sakai, Japan

  • Department of Clinical Medicine (Biostatistics), School of Pharmacy, Kitasato University, Tokyo, Japan

  • Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved